Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.
After a battle and a full recovery, he has returned to full-time work and is able to enjoy activities he had before, such as ...
The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide treatment decisions for patients with advanced prostate cancer. The guide, ...
As a retired clinical laboratorian, retired hospital laboratory manager, and prostate-cancer survivor, I feel I must respond to the articles “Fewer Men Diagnosed With Prostate Cancer” and “Restricting ...
A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...
Comprehensive genetic testing using multigene testing panels for prostate cancer can arm genetic counselors with the information they need to guide precision therapy, even in men with early stage ...
Cases of advanced prostate cancer have increased among American men ages 50 and older, while cases of early-stage disease have declined, a study published Wednesday found. The study looked at cases ...
Some patients with prostate cancer may want to consider genetic testing as it could provide a guideline for treatment and information for secondary cancer risk, while also allowing families to better ...
Prostate-specific antigen screening was highest among African American men and those concerned about prostate cancer and lowest when physicians did not discuss the test. Objective: To examine factors ...
Ever felt like you're just waiting for the other shoe to drop, especially regarding medical test results? Francis Collins, the former NIH director, found himself in that situation, dancing the ...
Metastatic castration-resistant prostate cancer (CRPC) is the lethal form of the disease. Many groups have performed mutational or immunohistochemistry (IHC) testing in metastatic CRPC to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results